[go: up one dir, main page]

AR044953A1 - Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico - Google Patents

Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico

Info

Publication number
AR044953A1
AR044953A1 ARP040102287A ARP040102287A AR044953A1 AR 044953 A1 AR044953 A1 AR 044953A1 AR P040102287 A ARP040102287 A AR P040102287A AR P040102287 A ARP040102287 A AR P040102287A AR 044953 A1 AR044953 A1 AR 044953A1
Authority
AR
Argentina
Prior art keywords
lactic acid
batteries
produce equol
daidzein
equol
Prior art date
Application number
ARP040102287A
Other languages
English (en)
Inventor
Shigeto Uchiyama
Tomomi Ueno
Toshimi Suzuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR044953A1 publication Critical patent/AR044953A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Agronomy & Crop Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)

Abstract

Se provee una composición que contiene bacterias de ácido láctico que producen equol que es efectiva para la prevención y el alivio de malestares, inclusive los trastornos climatéricos en mujeres de mediana edad y mayores, para las cuales no se encuentran disponibles hasta el momento métodos profilácticos o medios de alivio efectivos. Esta composición que contiene bacterias de ácido láctico que producen equol comprende, como un componente esencial de la misma, bacterias de ácido láctico del género Lactococus que tienen la capacidad de utilizar por lo menos un compuesto de daidzeína seleccionado entre el grupo que consiste en glicósido de daidzeína, daidzeína y dihidrodaidzeína para elaborar equol. Reivindicación 5: La composición de acuerdo con la reivindicación 4, caracterizada porque el ingrediente que contiene el compuesto de daidzeína es harina de porotos de soja o leche de soja.
ARP040102287A 2003-06-30 2004-06-30 Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico AR044953A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003187831 2003-06-30

Publications (1)

Publication Number Publication Date
AR044953A1 true AR044953A1 (es) 2005-10-12

Family

ID=33549734

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102287A AR044953A1 (es) 2003-06-30 2004-06-30 Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico

Country Status (21)

Country Link
US (3) US8765445B2 (es)
EP (2) EP1649760B1 (es)
JP (1) JP3864317B2 (es)
KR (2) KR101054631B1 (es)
CN (1) CN1826059B (es)
AR (1) AR044953A1 (es)
AU (1) AU2004251563B2 (es)
BR (1) BRPI0412180B1 (es)
CA (1) CA2531173C (es)
CY (2) CY1114248T1 (es)
DK (2) DK2548455T3 (es)
ES (2) ES2601885T3 (es)
HU (1) HUE030615T2 (es)
MX (1) MXPA06000074A (es)
MY (1) MY146563A (es)
PL (2) PL1649760T3 (es)
PT (2) PT1649760E (es)
SG (1) SG157232A1 (es)
SI (2) SI2548455T1 (es)
TW (2) TWI335353B (es)
WO (1) WO2005000042A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3864317B2 (ja) * 2003-06-30 2006-12-27 大塚製薬株式会社 エクオール産生乳酸菌含有組成物
JP4811760B2 (ja) * 2004-12-27 2011-11-09 独立行政法人農業・食品産業技術総合研究機構 ダイゼイン資化によるエコール生成能を改善するための腸内細菌およびその利用
EP1944021B1 (en) * 2005-11-02 2014-05-21 Kabushiki Kaisha Yakult Honsha Equol level regulator
EP2474237B1 (en) 2005-12-06 2018-04-25 Otsuka Pharmaceutical Co., Ltd. Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
JP2007308428A (ja) * 2006-05-19 2007-11-29 Fancl Corp 摂食抑制剤
JP5122766B2 (ja) * 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
JP5517613B2 (ja) * 2007-05-28 2014-06-11 不二製油株式会社 エクオール非産生者用の血中エクオール産生促進組成物
ES2861301T3 (es) * 2007-06-13 2021-10-06 Otsuka Pharma Co Ltd Gelatina y bebida que contienen equol
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
CN101868152A (zh) * 2007-11-23 2010-10-20 荷兰联合利华有限公司 发酵的大豆基饮料
SG2013066634A (en) * 2007-12-27 2015-04-29 Otsuka Pharma Co Ltd Enzyme associated with equol synthesis
JP2009232712A (ja) * 2008-03-26 2009-10-15 Glico Dairy Products Co Ltd エクオール産生組成物，エクオール産生方法及びエクオール含有組成物
KR101600867B1 (ko) * 2008-06-03 2016-03-10 삼성전자주식회사 냉장고
AU2014240200B2 (en) * 2008-09-19 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
TWI621712B (zh) * 2008-09-19 2018-04-21 大塚製藥股份有限公司 含有維持雌馬酚（ｅｑｕｏｌ）產生能力之產生雌馬酚之微生物的發酵製品及其製造方法（二）
CN102317435B (zh) * 2009-02-25 2014-08-06 株式会社益力多本社 雌马酚产生菌及其利用
JP2011036190A (ja) * 2009-08-12 2011-02-24 Enseki Aojiru Kk 顆粒状経口食品の製造方法及びその顆粒状経口食品
JP5777287B2 (ja) * 2009-09-18 2015-09-09 大塚製薬株式会社 エクオール産生能が維持されたエクオール産生微生物を含む発酵製品、及びその製造方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
CN102021130A (zh) * 2010-10-21 2011-04-20 南京农业大学 一株降解大豆苷原产生雌马酚的双酶梭菌及其菌剂和应用
US20120251511A1 (en) * 2011-03-28 2012-10-04 Eric Donald Murphy Composition and products for enabling the production of equol in vivo
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR101307947B1 (ko) 2011-11-30 2013-09-12 씨제이제일제당 (주) 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제
JP5996187B2 (ja) * 2011-12-20 2016-09-21 株式会社ダイセル エクオールの製造方法
EP2832859B1 (en) * 2012-03-30 2018-07-25 Ajinomoto Co., Inc. Diabetes-inducible bacterium
CN104087532B (zh) * 2014-07-04 2016-04-20 浙江省农业科学院 一种来源于鸡肠道的雌马酚产生梭菌c1-6及应用
KR102064055B1 (ko) 2018-02-08 2020-01-08 신선옥 에쿠올이 생성된 발효커피생두, 그 제조방법 및 그 추출물
JP2018186823A (ja) * 2018-07-13 2018-11-29 株式会社ダイセル イソフラバノン類の製造方法
WO2020210194A1 (en) * 2019-04-08 2020-10-15 Corn Products Development, Inc. Improved plant-protein based analog dairy compositions
WO2020210540A2 (en) * 2019-04-09 2020-10-15 Martin Munzer Nutrient compositions and methods for administering a nutrient composition
US11730778B2 (en) * 2019-09-24 2023-08-22 Access Business Group International Llc Method of increasing the level and production of metabolized phytonutrients in a subject
JPWO2021235278A1 (es) * 2020-05-21 2021-11-25
CN114150030B (zh) * 2021-12-24 2024-05-14 内蒙古金达威药业有限公司 一种透明质酸的生产方法
CN119173160A (zh) * 2022-05-19 2024-12-20 株式会社大赛璐 包含雌马酚的食品组合物及其制造方法
JP7484031B1 (ja) 2023-11-09 2024-05-15 株式会社ダイセル 組成物の製造方法及び飲食品の製造方法
WO2025099959A1 (ja) * 2023-11-09 2025-05-15 株式会社ダイセル 組成物の製造方法、飲食品の製造方法及び発酵組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69832516T2 (de) 1997-08-08 2006-07-27 Otsuka Pharmaceutical Co., Ltd. Isoflavon-enthaltende zusammensetzungen
WO2004009035A2 (en) * 2002-07-24 2004-01-29 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
JP2003081855A (ja) 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
JP4889944B2 (ja) * 2002-10-29 2012-03-07 コロラド ステート ユニバーシティー リサーチ ファウンデーション アンドロゲンによって仲介される疾患を治療するためのエクオールの使用
JP3864317B2 (ja) * 2003-06-30 2006-12-27 大塚製薬株式会社 エクオール産生乳酸菌含有組成物

Also Published As

Publication number Publication date
ES2601885T3 (es) 2017-02-16
SI2548455T1 (sl) 2016-11-30
KR20110044810A (ko) 2011-04-29
CY1114248T1 (el) 2016-08-31
AU2004251563A1 (en) 2005-01-06
CN1826059A (zh) 2006-08-30
TWI335353B (en) 2011-01-01
CN1826059B (zh) 2011-09-28
MXPA06000074A (es) 2006-03-21
EP1649760A1 (en) 2006-04-26
KR101043465B1 (ko) 2011-06-23
HK1090812A1 (en) 2007-01-05
KR20060028436A (ko) 2006-03-29
SG157232A1 (en) 2009-12-29
CA2531173A1 (en) 2005-01-06
DK2548455T3 (en) 2016-11-28
CY1118534T1 (el) 2017-07-12
PL2548455T3 (pl) 2017-03-31
TW200510542A (en) 2005-03-16
MY146563A (en) 2012-08-30
SI1649760T1 (sl) 2013-07-31
PL1649760T3 (pl) 2013-10-31
PT2548455T (pt) 2016-11-09
CA2531173C (en) 2013-09-10
AU2004251563B2 (en) 2009-04-23
JP3864317B2 (ja) 2006-12-27
TW201118175A (en) 2011-06-01
JPWO2005000042A1 (ja) 2006-07-27
EP1649760A4 (en) 2008-06-25
ES2417481T3 (es) 2013-08-08
HUE030615T2 (en) 2017-05-29
US20140050703A1 (en) 2014-02-20
EP2548455B1 (en) 2016-08-31
KR101054631B1 (ko) 2011-08-04
US8765445B2 (en) 2014-07-01
US20190038684A1 (en) 2019-02-07
EP1649760B1 (en) 2013-05-22
US10098915B2 (en) 2018-10-16
US20060148045A1 (en) 2006-07-06
BRPI0412180B1 (pt) 2014-06-17
DK1649760T3 (da) 2013-07-08
EP2548455A1 (en) 2013-01-23
PT1649760E (pt) 2013-06-25
BRPI0412180A (pt) 2006-08-22
WO2005000042A1 (ja) 2005-01-06

Similar Documents

Publication Publication Date Title
AR044953A1 (es) Bacterias de acido lactico que producen equol, una composicion que comprende dichas bacterias de acido lactico y un metodo para producir equol utilizando dichas bacterias de acido lactico
KR100352030B1 (en) Gum composition for removing nicotine
IL162646A0 (en) A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
IN2012DN02663A (es)
JPWO2007094312A1 (ja) ビタミンｃトランスポーター産生促進剤
BR0312232A (pt) Inibidores de caspases e seus usos
EA200870526A1 (ru) Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia
IL183292A0 (en) Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum
BRPI0511322A (pt) composições adequadas para o tratamento de sinais cutáneos provenientes do envelhecimento, tablete e formulação de tablete
CA2503363A1 (en) Antioxidative compositions
CN108619078A (zh) 一种美白亮肤面膜及其制备方法
WO2001089520A3 (en) Dehydroascorbic acid formulations and uses thereof
AU2013303762B2 (en) Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using Ageratum spp.
ATE235885T1 (de) Antioxidative hautpflegemittel
JP2004091338A (ja) ウレアーゼ阻害剤、アンモニア臭抑制剤およびおむつかぶれ防止剤
ES2195939T3 (es) Composicion para prevencion y/o tratamiento de trastornos circulatorios que comprende derivados de l-carnitina y extractos de ginkgo biloba.
AR047765A1 (es) Metodos y composiciones que comprenden ilex
DK1638582T3 (da) Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
WO2007077203A3 (en) Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
WO2014144584A3 (en) Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
WO2005051290A3 (en) Methods and formulations for the treatment of medical conditions related to elevated dihydrotestosterone
KR101284607B1 (ko) 천연물질을 함유한 저자극성 염모제
WO2006047590A3 (en) Compositions and treatments of bacterial vaginosis
CN106511108A (zh) 一种含白藜芦醇的美白补水面膜泥及其制备方法与应用

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee